glossodynia
Conditions
Interventions
Goreisan treatment
Sponsors
Ayuse Takao
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. For patients undergoing treatment for glossodynia 2. Age: Adult patients aged over 20 years of age at the time of consent acquisition 3. Gender: Any question 4. hospitalization / outpatient: outpatient only 5. Patients who received written consent by their own free will after thorough understanding before participating in this study
Exclusion criteria
Exclusion criteria: 1.Patients taking Kampo medicines including Goreisan 2.Severe hypertension patients with diastolic blood pressure of 120mmHg or more 3.Patients with severe liver and renal dysfunction 4.Patients with drug hypersensitivity such as allergy 5.Pregnant women and patients who may be pregnant or lactating 6.Patients who participated in another clinical study within 4 months 7.Other patients that the investigator judged to be inappropriate as the study subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-filled pain scale (VAS) (Evaluation 12 weeks after administration is the main evaluation point.) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. VAS 2.Salivary amylase activity 3 Tongue examination (whether the veins in the back of the tongue are inflated) 4. Relation to weather information (pressure) (Evaluation 4 weeks and 8 weeks after administration is the main evaluation point.) | — |
Contacts
Public ContactTakao Ayuse
Nagasaki University Hospital
Outcome results
None listed